The detection of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol in human dried blood spots

Analytical Methods

Volumn 3, Issue 5, 2011, Pages 1101-1106

  Jones, Joseph ^a   Jones, Mary ^a   Plate, Charles ^a   Lewis, Douglas ^a  

^a US Drug Testing Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL ABUSE; DRIED BLOOD SPOTS; INVASIVENESS; PHOSPHOLIPASE D; REDUCED COST; TANDEM MASS SPECTROMETRIC; WHOLE BLOOD;

ETHANOL; LIQUID CHROMATOGRAPHY; PHOSPHOLIPIDS;

BLOOD;

EID: 79959694858     PISSN: 17599660     EISSN: 17599679     Source Type: Journal    
DOI: 10.1039/c0ay00636j     Document Type: Article

References (33)

1. National Institute on Alcohol Abuse and Alcoholism, Epidemiology: How Common is Alcohol and Other Drug Addiction, Alcohol Alert, Rockville, MD, 2008, vol. 76
2. http://www.healthypeople.gov/Document/pdf/Volume2/26Substance.pdf
3. P. Bean, Medical Laboratory Observer-Online, 2005, p. 10
4. S. Hartmann S. Aradottir M. Graf G. Wiesbeck O. Lesch K. Ramskogler M. Wolferdorf C. Alling F. Wurst Addict. Biol. 2006 12 81
5. F. Wurst C. Kempter S. Seidl A. Alt Alcohol Alcohol. 1999 34 71
6. A. Helander I. Olsson H. Dahl Clin. Chem. 2005 51 1728
7. A. Helander I. Olsson H. Dahl Clin. Chem. 2007 53 1855
8. A. Costantino E. DiGregorio W. Korn S. Spayd F. Rieders J. Anal. Toxicol. 2006 30 659
9. T. Rohrig C. Huber L. Goodson W. Ross J. Anal. Toxicol. 2006 30 703
10. Garlick, et al. v. Quest Diagnostics, Inc., et al., No. 06-6244, DNJ, 2007
11. Byrum, et al. v. Compass Vision and National Medical Services, Inc., No. 3:2009cv02016m, DCA, 2009
12. Clark v. FirstLab, et al., No. 06-27461, Court of Common Pleas, Montgomery County, PA, 2006
13. Center for Substance Abuse Treatment, The Role of Biomarkers in the Treatment of Alcohol Use Disorders, Substance Abuse Treatment Advisory, 2006, vol. 5, issue 4
14. B. Appenzeller R. Agirman P. Neuberg M. Yegles R. Wennig Forensic Sci. Int. 2007 173 87
15. F. Pragst M. Rothe B. Moench M. Hastedt S. Herre D. Simmert Forensic Sci. Int. 2010 196 101
16. J. Klein T. Karaskov G. Koren Ther. Drug Monit. 1999 21 644
17. S. Hartwig V. Auwarter F. Pragst Forensic Sci. Int. 2003 131 90
18. C. Alling L. Gustavsson E. Anggard FEBS Lett. 1983 152 24
19. L. Gustavsson C. Alling Biochem. Biophys. Res. Commun. 1987 142 958
20. M. Kobayashi J. Kanfer J. Neurochem. 1987 48 1597
21. L. Gustavsson Alcohol Alcohol. 1995 30 391
22. A. Varga P. Hansson G. Johnson C. Alling Clin. Chim. Acta 2000 299 141
23. T. Gunnarsson A. Karlsson P. Hansson G. Johnson C. Alling G. Odham J. Chromatogr., B: Biomed. Sci. Appl. 1998 705 234
24. A. Helander Y. Zheng Clin. Chem. 2009 55 1395
25. A. Varga C. Alling J. Lab. Clin. Med. 2002 140 79
26. C. Yon M. Lee D. Oh D. Kim K. Lee J. Han Arch. Pharmacal Res. 2003 26 478
27. S. Aradottir S. Seidl F. Wurst B. Jonsson C. Alling Alcohol.: Clin. Exp. Res. 2004 28 1718
28. S. Aradottir K. Moller C. Alling Alcohol Alcohol. 2004 39 8
29. Guidance for Industry: Bioanalytical Method Validation, United States Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation Research, Center for Veterinary Medicine, 2001
30. Off. J. Eur. Communities: Legis., 2002, 221, 8
31. B. Matuszewski M. Constanzer C. Chavez-Eng Anal. Chem. 2003 75 3019
32. B. Matuszewski J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2006 830 293
33. A. Eeckhaut K. Lanckmans S. Sarre I. Smolders Y. Michotte J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2009 877 2198